News - Medical and health professional investment - VC and PE investment business - Shenzhen Efung Investment Management Co. Ltd.

发布时间: 2026 - 04 - 02

When AI Starts "Guiding" Doctors: A New Assistant or a New Rival for Medical Professionals

Editor's NoteLast month, a doctor friend shared his confusion with me.A patient had just sat down when he thrust his phone in front of the doctor. The screen was densely packed with AI-generated "treatment recommendations"—from medication plans to lifestyle restrictions, covering every detail. With a hint of scrutiny, the patient asked: "Doctor, the AI says this medication has serious side effects. Your prescription is different. Could you double-check?"My friend was stunned. He had encountered patients who came with Baidu search results to "argue their case,"...

浏览次数：3

查看详情>>

发布时间: 2026 - 03 - 24

Efung Capital CEO Zhu Pai Attends BIOCHINA 2026: Discussing the New Ecosystem of LP-GP Collaboration

In March, Suzhou is gradually embracing the vitality of spring, much like China's biomedical industry, which is gathering momentum amidst transformation. On March 13, during the 11th BioChina Summit (BIOCHINA 2026), Mr. Zhu Pai, CEO of Efung Capital, was invited to attend the core session—the Global Investment Forum—where he engaged in in-depth discussions with industry peers on the theme "LP-GP Ecosystem Synergy: Coordinating Policy, Capital, and Innovation."Efung Capital CEO Zhu Pai Attends BIOCHINA 2026: Discussing the New Ecosystem of LP-GP Collaboration, Standing as "Ba...

浏览次数：8

查看详情>>

发布时间: 2026 - 04 - 28

Huahaizhongtian's Utidelone Receives Another FDA Orphan Drug Designation | Feng Investment News

On September 25, Beijing Huahaizhongtian Biopharmaceutical Co., Ltd. (hereinafter referred to as "Huahaizhongtian," stock code: 2563.HK) announced that its core product, Utidelone, has been granted another Orphan Drug Designation by the U.S. Food and Drug Administration (FDA), this time for the treatment of pancreatic cancer. This marks the third Orphan Drug Designation granted to Utidelone by the FDA, following those for breast cancer brain metastases and gastric cancer.Pancreatic cancer is a highly malignant tumor, often referred to as the "king of cancers" due ...

浏览次数：0

查看详情>>

发布时间: 2026 - 04 - 03

Yewei Medical Completes Nearly 100M RMB Series B to Strengthen Cardiovascular Surgery Footprint

Recently, Beijing Yewei Medical Technology Co., Ltd. ("Yewei Medical") announced the completion of a nearly 100 million RMB equity financing round. This round was led by Fenix Capital, with participation from Beishang Capital and Bohai Chuangfu, and Kaicheng Capital serving as the exclusive financial advisor.This marks Yewei Medical's second substantial financing round within the year, fully reflecting the capital market's strong recognition of the company's development trajectory. Supported by this financing, Yewei Medical will continue to comprehensively strengthen its ...

浏览次数：3

查看详情>>